Anna-Maria Dutius Andersson Selected Research

A 285222

1/2018

In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna-Maria Dutius Andersson Research Topics

Disease

1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Pathologic Constriction (Stenosis) 01/2018

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018
1	A 285222IBA 01/2018

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2018